SLC16A1 and prostate neoplasm: These results suggest that in the present cohort consisting of low- and intermediate-risk PCa, [1-13C]lactate labelling was driven predominantly by the combined LDH expression rather than MCT1, which had been shown to play an important role in a previous clinical study assessing a different patient cohort with higher grade prostate tumours in comparison to the population studied here21.